Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pei Tu Ning Feng Tang is a Traditional Chinese Medicine (TCM) herbal decoction developed for the treatment of Tourette Syndrome (TS), specifically targeting the "Spleen Deficiency and Liver Hyperactivity" syndrome type. The formulation is a combination of seven herbs: *Codonopsis pilosula* (Dangshen), *Astragalus membranaceus* (Huangqi), *Atractylodes macrocephala* (Baizhu), *Poria cocos* (Fuling), *Paeonia lactiflora* (Hangshao), *Uncaria rhynchophylla* (Gouteng), and *Glycyrrhiza uralensis* (Zhi Gancao). It is hypothesized to exert its therapeutic effects by modulating the dopamine (DA)-MAPK-BDNF signaling pathway, influencing gut microbiota composition, and regulating stress hormones and cytokines. Clinical evaluation involves the use of functional near-infrared spectroscopy (fNIRS) to observe brain function activation and the Yale Global Tic Severity Scale (YGTSS) to measure symptom reduction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pei Tu Ning Feng Tang.